Primaquine diphosphate

CAS No. 63-45-6

Primaquine diphosphate( NSC 149765 )

Catalog No. M15396 CAS No. 63-45-6

Primaquine is the only generally available anti-malarial that prevents relapse in vivax and ovale malaria, and the only potent gametocytocide in falciparum malaria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 37 In Stock

Biological Information

  • Product Name
    Primaquine diphosphate
  • Note
    Research use only, not for human use.
  • Brief Description
    Primaquine is the only generally available anti-malarial that prevents relapse in vivax and ovale malaria, and the only potent gametocytocide in falciparum malaria.
  • Description
    Primaquine is the only generally available anti-malarial that prevents relapse in vivax and ovale malaria, and the only potent gametocytocide in falciparum malaria.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 149765
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    63-45-6
  • Formula Weight
    455.34
  • Molecular Formula
    C15H21N3O9·2H3PO4
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 91 mg/mL (199.85 mM); DMSO: 91 mg/mL (199.85 mM)
  • SMILES
    CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2.OP(=O)(O)O.OP(=O)(O)O
  • Chemical Name
    4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Heard CM, et al. Int J Pharm. 2003, 257(1-2):237-44.
molnova catalog
related products
  • 2,4-Dihydroxydihydro...

    2',4'-Dihydroxydihydrochalcone has cytotoxic, and anti-inflammatory activities.

  • dTAG-47

    dTAG-47, heterobifunctional dTAG molecule, targets mutant FKBP12 (FKBP12F36V). FKBP12F36V serves as a degradation tag (dTAG) and is fused to a protein of interest. dTAG-47 can be used for the research of basal-like breast cancers (BBC).

  • GRGDSP TFA

    GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.